The new top 10 most expensive drugs on the planet
BioMarin’s decision last night to set the wholesale acquisition cost of its new ultra rare disease drug Brineura for CLN2 at $702,000 — with a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
